SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: mopgcw who wrote (918)4/26/2004 12:25:29 AM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 3559
 
I never thought that NVS is serious treat to France nationalist, but for those who had this is relief.

Reuters
Aventis Accepts Sweetened Sanofi Bid
Sunday April 25, 7:29 pm ET
By Noelle Mennella

PARIS (Reuters) - Franco-German Aventis (Paris:AVEP.PA - News) has accepted an improved 53.7 billion euros ($63.81 billion) takeover bid from Sanofi-Synthelabo (Paris:SASY.PA - News) in a move creating the world's third-largest drug company, people familiar with the situation said.<snip>